Mereo BioPharma (MREO) Reports In-Line Q2 EPS
Mereo BioPharma (NASDAQ: MREO) reported Q2 EPS of ($0.01), in-line with the analyst estimate of ($0.01).
For earnings history and earnings-related data on Mereo BioPharma (MREO) click here.
Mereo BioPharma (NASDAQ: MREO) reported Q2 EPS of ($0.01), in-line with the analyst estimate of ($0.01).
For earnings history and earnings-related data on Mereo BioPharma (MREO) click here.